Correlation Between AlzeCure Pharma and NextCell Pharma
Can any of the company-specific risk be diversified away by investing in both AlzeCure Pharma and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AlzeCure Pharma and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AlzeCure Pharma and NextCell Pharma AB, you can compare the effects of market volatilities on AlzeCure Pharma and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AlzeCure Pharma with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AlzeCure Pharma and NextCell Pharma.
Diversification Opportunities for AlzeCure Pharma and NextCell Pharma
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between AlzeCure and NextCell is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding AlzeCure Pharma and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and AlzeCure Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AlzeCure Pharma are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of AlzeCure Pharma i.e., AlzeCure Pharma and NextCell Pharma go up and down completely randomly.
Pair Corralation between AlzeCure Pharma and NextCell Pharma
Assuming the 90 days trading horizon AlzeCure Pharma is expected to under-perform the NextCell Pharma. But the stock apears to be less risky and, when comparing its historical volatility, AlzeCure Pharma is 2.02 times less risky than NextCell Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The NextCell Pharma AB is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 741.00 in NextCell Pharma AB on October 21, 2024 and sell it today you would lose (501.00) from holding NextCell Pharma AB or give up 67.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AlzeCure Pharma vs. NextCell Pharma AB
Performance |
| Timeline |
| AlzeCure Pharma |
| NextCell Pharma AB |
AlzeCure Pharma and NextCell Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AlzeCure Pharma and NextCell Pharma
The main advantage of trading using opposite AlzeCure Pharma and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AlzeCure Pharma position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.| AlzeCure Pharma vs. Filo Mining Corp | AlzeCure Pharma vs. Lundin Mining | AlzeCure Pharma vs. FormPipe Software AB | AlzeCure Pharma vs. Redsense Medical AB |
| NextCell Pharma vs. Diamyd Medical AB | NextCell Pharma vs. Mendus AB | NextCell Pharma vs. Vicore Pharma Holding | NextCell Pharma vs. Immunovia publ AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |